| Patients characteristics |
No. |
Percentage (%) |
| Age |
| ≤60 years |
49 |
75.4% |
| >60 years |
16 |
24.6% |
| Sex |
|
|
| Male |
39 |
60% |
| Female |
26 |
40% |
| FAB Classification |
| M0 |
3 |
4.6% |
| M1 |
12 |
18.5% |
| M2 |
22 |
33.8% |
| M4 |
14 |
21.5% |
| M5 |
8 |
12.3% |
| M6 |
4 |
6.3% |
| Undifferentiated |
2 |
3.1% |
| Cytogenetic |
| Favorable |
18 |
27.7% |
| Intermediate |
30 |
46.2% |
| Poor |
13 |
20% |
| Failed |
4 |
6.2% |
| No. of chemotherapy cycles to achieve complete remission |
| 1 |
37 |
56.9% |
| 2 |
26 |
40.7% |
| 3 |
2 |
3.1% |
| Hematogons |
| >0.01 |
25 |
38.5% |
| <0.01 |
40 |
61.5% |
|
